Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
Clinical trial NCT07653477 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07653477
- Sponsor
- The United Bio-Technology (Hengqin) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2028-02-29
- Enrollment
- 956
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.